gallium

Gallium maltolate is a ribonucleoside-diphosphate reductase inhibitor.

Gallium 8-Hydroxyquinolinate is an inducer of apoptosis that initiates both p53-dependent and independent cell death in cancer cells through the induction of Ca2+ signaling transduction. In addition to its apoptotic properties, this compound's nanostructures exhibit excellent optical performance, making it suitable for use in tumor research.

MiADMSA (Monoisoamyl DMSA) is a lipophilic chelating agent that has shown potential as a chelator detoxifier for arsenic and several heavy metals, including lead, mercury, cadmium, and gallium arsenide. It mitigates oxidative stress induced by sodium tungstate and improves liver and immune system alterations caused by chronic copper poisoning in Sprague Dawley rats. Additionally, MiADMSA protects human keratinocytes ['HaCaT'] from arsenic-induced oxidative stress.

Dotanoc is a ligand to make gallium Ga 68-DOTANOC, which is a gallium Ga 68-radiolabeled analog of somatostatin.

PSMA-11 (HBED-CC-PSMA) detects prostate cancer recurrence and metastasis by binding to the extracellular structural domain of prostate-specific membrane antigen (PSMA).PSMA-11 is often used as a tracer of PSMA-expressing tumours in positron emission tomography (PET) scanning by intravenous injection of gallium Ga 68-labelled PSMA-11, Glu-urea-Lys(Ahx) molecule targeted and bound PSMA-expressing tumour cells. After internalisation, PSMA-expressing tumour cells could be detected on PET imaging.

Pentixafor is a peptide that selectively targets the CXCR4 receptor and can be labeled with Gallium-68 (68Ga) for visualization using positron emission tomography (PET) imaging [1].